Company profile: Xcenda
1.1 - Company Overview
Company description
- Provider of strategic consultancy and managed markets agency services delivering strategic insights, health economics and outcomes research (HEOR) expertise, and reimbursement support to global companies and emerging pre-commercialization phase firms, with 20+ years of real-world experience.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xcenda
Curapath
HQ: Spain
Website
- Description: Provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curapath company profile →
mAbxience
HQ: Switzerland
Website
- Description: Provider of biologic products, mainly biosimilar drugs, specializing in research, development and manufacture. Established in Europe in 2009, the multinational biopharmaceutical group operates internationally with a strong presence in major pharmaceutical markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full mAbxience company profile →
Aptuit
HQ: United States
Website
- Description: Provider of integrated CRO/CDMO services spanning early discovery to mid-phase drug development, including drug design and discovery, API development and manufacture, solid state chemistry, CMC, preclinical, and IND-enabling GLP/GMP programs. Offers an AI-powered PanOmics platform, iPSC-based disease modeling, molecular glue degraders, neuroscience drug discovery, and biosimilar development via a partnership with Sandoz.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptuit company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
Pyxa Solutions
HQ: United States
Website
- Description: Provider of consulting, operational, and strategic services supporting life sciences teams.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxa Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xcenda
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xcenda
2.2 - Growth funds investing in similar companies to Xcenda
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xcenda
4.2 - Public trading comparable groups for Xcenda
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →